LIVING WITH CRC
Malnutrition identified as independent risk factor for cardiovascular toxicity from FOLFOX/XELOX chemotherapyA retrospective cohort study of 320 CRC patients found that malnutrition, present in up to 60% of post-surgical patients, may amplify cardiovascular toxicity from fluoropyrimidine- and oxaliplatin-based regimens through systemic inflammation and pharmacokinetic alterations. (Front Cardiovasc Med)